past
decad
microarray
revolution
scientif
world
dramat
internet
chang
everyday
life
initi
applic
dna
microarray
uncov
gene
express
pattern
diagnost
prognost
cancer
understand
interplay
immun
respons
diseas
prime
applic
technolog
recent
effort
move
beyond
genet
analysi
function
analysi
molecul
involv
includ
identif
immunodomin
antigen
peptid
well
role
posttransl
glycosyl
focu
recent
applic
microarray
technolog
understand
detail
chemic
biolog
immun
respons
diseas
effort
guid
develop
vaccin
protect
therapi
jennif
maynard
ryan
myhr
benjamin
roy
past
decad
microarray
revolution
scientif
world
dramat
internet
chang
everyday
life
initi
applic
dna
microarray
uncov
gene
express
pattern
diagnost
prognost
cancer
understand
interplay
immun
respons
diseas
prime
applic
technolog
recent
effort
move
beyond
genet
analysi
function
analysi
molecul
involv
includ
identif
immunodomin
antigen
peptid
well
role
posttransl
glycosyl
focu
recent
applic
microarray
technolog
understand
detail
chemic
biolog
immun
respons
diseas
effort
guid
develop
vaccin
protect
therapi
remark
live
rotaviru
vaccin
introduc
develop
use
essenti
empir
method
attenu
sabin
polio
vaccin
nearli
year
earlier
loss
virul
multipl
passag
nonhuman
cell
vaccin
seem
safe
effect
desper
need
prevent
death
annual
attribut
rotaviru
histori
underscor
despit
profound
role
vaccin
reduc
human
anim
morbid
mortal
field
reli
technolog
advanc
area
spur
develop
particular
dual
advanc
genom
sequenc
microarray
design
result
renaiss
research
immun
infecti
diseas
applic
microarray
span
bench
bedsid
provid
tool
requir
less
effort
expens
sampl
technolog
also
highli
multiplex
build
establish
patternrecognit
techniqu
statist
review
discuss
technic
aspect
common
array
eg
statist
analysi
immobil
chemistri
extens
review
elsewher
instead
limit
novel
applic
infect
immun
use
four
variant
array
technolog
dna
antigen
peptidemhc
complex
pmhc
carbohydr
figur
collect
technolog
alreadi
advanc
understand
interplay
immun
diseas
provid
ration
basi
design
vaccin
agent
interfer
diseas
progress
tabl
sinc
day
pasteur
pathogen
identif
accomplish
use
combin
cultur
serolog
techniqu
laborintens
requir
highli
train
personnel
incur
delay
hour
day
conclus
reach
furthermor
mani
organ
refractori
cultur
wherea
serotyp
limit
avail
specif
antisera
situat
especi
problemat
emerg
evolv
pathogen
consid
avail
numer
genom
sequenc
need
contain
rise
healthcar
cost
dna
microarray
simultan
probe
clinic
environment
sampl
presenc
conserv
viral
bacteri
sequenc
specif
virul
factor
antimicrobi
resist
gene
even
identifi
point
mutat
present
novel
altern
figur
concept
elegantli
illustr
panvir
dna
microarray
virochip
compris
highli
conserv
oligonucleotid
everi
partial
fulli
sequenc
viral
genom
genbank
june
third
gener
chip
includ
oligonucleotid
repres
sequenc
patient
sampl
collect
nasal
lavag
ribonucl
acid
purifi
reversetranscrib
amplifi
randomprim
pcr
final
incub
array
stringent
bind
condit
use
array
derisi
colleagu
abl
correctli
identifi
rang
virus
rna
infect
tissu
cultur
cell
human
sampl
impress
array
subsequ
use
identifi
isol
even
sequenc
base
viru
known
sever
acut
respiratori
syndrom
coronaviru
sarscov
origin
design
experiment
research
tool
virochip
also
seem
capabl
viral
diagnosi
clinic
set
although
success
virochip
impress
signific
hurdl
remain
broad
applic
technolog
primarili
term
sampl
amplif
probe
design
array
develop
oper
three
level
detail
use
surveil
diagnost
vaccin
develop
program
answer
follow
question
organ
present
array
level
includ
virochip
microarray
special
detect
virus
central
nervou
system
respiratori
pathogen
bacteri
strain
identif
importantli
chip
demonstr
abil
detect
bacteria
viabl
noncultur
state
amen
autom
clinic
presenc
gene
mutat
confer
antibiot
resist
influenc
treatment
option
wherea
transmiss
virul
factor
serotyp
use
strain
identif
indic
pathogen
potenti
organ
similarli
gene
differenti
present
pathogen
versu
commens
live
attenu
strain
guid
vaccin
develop
surveil
molecular
epidemiolog
program
develop
focus
array
track
antigen
drift
anticip
domin
serotyp
monitor
genom
live
attenu
vaccin
strain
instanc
lowdens
fluchip
distinguish
influenza
hemagglutinin
neuraminidas
subtyp
tile
resequenc
array
detect
singl
nucleotid
polymorph
within
gene
complement
specif
pathogen
hybrid
interrog
host
transcript
respons
primarili
use
peripher
blood
mononuclear
cell
premis
coronavirus
induc
similar
host
respons
respons
distinguish
induc
instanc
bacteri
sepsi
opportun
array
infect
immun
aspect
pathogen
access
array
analysi
includ
genet
materi
transmiss
element
gene
variant
bind
specif
tempor
express
carbohydr
lectin
involv
instanc
host
cell
attach
antigen
surfac
expos
secret
molecul
also
assess
genomewid
scale
aid
vaccin
diagnost
develop
host
perspect
array
reveal
immun
cell
respons
term
transcript
respons
antibodybind
specif
cellpmhc
reactiv
function
consequ
cell
activ
thu
transcript
profil
could
use
diagnos
diseas
complet
independ
knowledg
pathogen
even
pathogen
clear
system
despit
preliminari
success
approach
met
sever
obstacl
term
individu
heterogen
strong
stereotyp
inflammatori
respons
mediat
nuclear
factor
nfkb
obscur
pathogenspecif
respons
gene
harbor
organ
identifi
next
step
probe
host
immun
respons
gene
product
protein
antigen
recogn
confer
last
immun
antibodi
recognit
set
antigen
sensit
diagnos
diseas
immunodomin
antigen
candid
target
passiv
activ
vaccin
antigen
array
natur
fit
biomark
discoveri
complement
recent
advanc
vaccin
develop
one
advanc
term
revers
vaccinolog
capit
avail
genom
sequenc
pathogen
refractori
tradit
vaccin
develop
strategi
silico
techniqu
identifi
conserv
open
read
frame
orf
predict
encod
surfac
expos
secret
protein
hundr
clone
escherichia
coli
express
purifi
parallel
use
immun
mice
protein
either
protect
mice
subsequ
challeng
induc
sera
combinatori
chemistri
molecular
divers
array
use
studi
infect
immun
dna
array
immobil
dna
sequenc
chosen
repres
highli
conserv
region
broad
rang
organ
pan
virochip
use
diseas
diagnosi
altern
dna
chosen
special
detect
clinic
relev
gene
eg
antibiot
resist
export
pump
gene
key
antigen
serotyp
virul
factor
capabl
horizont
transmiss
sampl
nucleic
acid
purifi
fluoresc
label
allow
specif
hybrid
immobil
complementari
dna
ii
use
resequenc
array
provid
singl
base
pair
inform
use
track
genet
drift
singl
nucleotid
polymorph
b
antigen
array
monitor
humor
immun
open
read
frame
peptid
genom
express
recombinantli
purifi
immobil
array
serum
infect
recov
vaccin
individu
incub
array
bound
antibodi
detect
subsequ
incub
fluoresc
label
secondari
antibodi
array
use
rapidli
character
protect
immunom
organ
identifi
novel
vaccin
candid
compar
vaccineinduc
humor
respons
result
natur
infect
c
pmhc
array
monitor
cellular
immun
varieti
solubl
peptidemhc
pmhc
complex
immobil
costimulatori
antibodi
form
array
artifici
antigenpres
cell
fluoresc
label
cell
popul
incub
array
quantifi
fraction
specif
given
pmhc
addit
antibodi
codeposit
pmhc
captur
local
secret
cytokin
sandwich
assay
illustr
interleukin
interferong
natur
cytokin
releas
reveal
respons
cell
stimul
particular
pmhc
use
secondari
antibodi
differ
fluoresc
label
assay
multiplex
detect
multipl
cytokin
simultan
glycoarray
lectin
array
monosaccharid
oligosaccharid
polysaccharid
vari
sequenc
structur
addit
glycoprotein
lectin
immobil
array
fluoresc
label
protein
virus
bacteri
cell
appli
array
assess
carbohydratebind
specif
exampl
speci
specif
bird
human
influenza
variant
attribut
glycanbind
propensitit
respect
hemagglutinin
variant
case
lectin
array
array
rapidli
assess
natur
glycan
attach
protein
cell
surfac
protect
vitro
assay
pursu
first
appli
serotyp
b
neisseria
meningococcu
research
ultim
queri
metagenom
databas
use
sequenc
data
eight
strain
five
antigen
identifi
none
broadli
protect
alon
togeth
induc
bactericid
antibodi
mice
meningococc
strain
key
element
revers
vaccinolog
analysi
immun
sera
reactiv
protein
antigen
array
begin
play
role
instead
immun
mice
directli
protein
correspond
entir
orfeom
fraction
lysat
spot
onto
glass
slide
convales
immun
sera
appli
array
follow
fluoresc
secondari
antibodi
eg
goat
antimous
igg
wash
array
scan
fluoresc
intens
use
indic
presenc
antibodi
recogn
antigen
immobil
spot
figur
way
antigen
protein
rapidli
recogn
respons
individu
vaccin
infect
monitor
infect
past
present
diagnos
therapeut
monoclon
antibodi
destin
passiv
vaccin
also
document
crossreact
broad
scale
array
develop
multipl
diseas
includ
tuberculosi
yersinia
pesti
neisseria
meningitidi
leprosi
hiv
also
autoimmun
diseas
tumorassoci
antigen
earli
success
includ
vaccinia
viral
array
consist
protein
probe
use
sera
immun
mice
nonhuman
primat
human
interestingli
three
speci
recogn
subset
viral
protein
array
later
use
identifi
envelop
protein
immunodomin
antigen
live
viral
vaccin
perhap
pave
way
less
traumat
subunit
vaccin
similarli
diagnost
array
repres
entir
orfeom
sarscov
portion
five
addit
coronavirus
develop
test
use
serum
canadian
chines
patient
array
shown
least
sensit
specif
enzymelink
immunosorb
assay
elisa
test
diagnos
sar
requir
minim
sampl
process
compar
genom
chip
cellular
respons
alway
harder
studi
antibodi
respons
antigen
bind
oppos
highaffin
bind
reaction
two
solubl
molecul
involv
low
affin
trimolecular
interact
compris
two
membranebound
molecul
posttransl
process
peptid
standpoint
vaccin
develop
target
therapi
import
identifi
amino
acid
sequenc
correspond
key
peptid
epitop
also
function
cell
respons
result
recognit
given
constraint
hard
imagin
screen
technolog
involv
cellular
readout
phage
cdna
display
technolog
wide
use
studi
antibodyantigen
interact
difficult
appli
analysi
cell
receptor
tcr
pmhc
interact
nongenet
approach
involv
incub
synthet
peptid
antigenpres
cell
cell
stimulatori
peptid
identifi
interleukin
releas
comput
predict
method
especi
class
mhc
also
improv
still
requir
experiment
valid
epitop
identifi
enzymelink
immunosorb
spot
elispot
flow
cytometri
assay
use
tetramer
pmhc
found
wisespread
use
monitor
spatial
tempor
presenc
cognat
cell
opportun
array
analysi
cellular
immun
threefold
quantifi
fraction
cell
popul
react
given
pmhc
ii
identifi
crucial
peptid
epitop
candid
sequenc
iii
assess
cell
respons
result
recognit
peptid
recent
report
devis
strategi
achiev
goal
use
pmhc
array
current
form
featur
array
contain
immobil
pmhc
molecul
costimulatori
antibodi
cytokin
captur
antibodi
thu
fluoresc
cell
recogn
particular
pmhc
bind
spot
activ
secret
cytokin
local
cytokin
captur
subsequ
detect
use
fluoresc
antibodi
figur
number
cell
bound
spot
count
replic
flow
cytometri
assay
cellular
respons
also
elucid
base
cytokin
releas
variat
design
reveal
detail
consequ
bind
singl
pmhc
use
multicolor
secondari
antibodi
quantifi
level
seri
cytokin
peptid
sequenc
use
array
peptid
variant
identifi
agonist
antagonist
peptid
initi
report
use
pmhc
microarray
stone
et
al
use
modifi
approach
match
cell
line
activ
viral
epitop
first
clinic
applic
technolog
chen
et
al
use
array
analyz
patient
cell
respons
peptid
vaccin
melanoma
ten
patient
immun
cell
respons
seven
pmhc
secret
factor
measur
use
array
interestingli
investig
abl
detect
fraction
cell
abund
low
one
cell
identifi
correl
function
profil
clinic
outcom
patient
earli
success
indic
pmhc
array
might
use
broadli
vaccin
therapeut
develop
instanc
could
identifi
tumorassoci
antigen
panel
candid
target
tcr
therapeut
could
identifi
viral
peptid
inclus
epitop
vaccin
convers
array
could
use
deimmun
therapeut
protein
although
yet
demonstr
experi
could
also
invert
use
solubl
tcr
captur
cell
present
specif
pmhc
diagnosi
assess
vaccineinduc
cellular
immun
carbohydr
consist
sugar
unit
includ
monosaccharid
disaccharid
oligosaccharid
polysaccharid
link
protein
linear
branch
extens
vari
connect
molecul
profoundli
affect
protein
fold
solubl
pathogen
infect
immun
system
respons
form
basi
sever
vaccin
eg
haemophilu
influenza
type
b
howev
intrins
heterogen
nontemplatedriven
biosynthesi
identifi
character
linkag
sugar
group
exampl
hplc
enzymat
releas
carbohydr
difficult
recent
ongo
develop
glycan
array
motiv
larg
consortium
function
glycom
http
wwwfunctionalglycomicsorg
made
possibl
sever
technic
breakthrough
includ
advanc
carbohydr
immobil
first
array
consist
varieti
sugar
deposit
slide
use
profil
glycanbind
specif
fluorescentlylabel
anticarbohydr
monoclon
antibodi
lectin
bacteri
toxin
might
use
futur
develop
multival
toxin
inhibitor
peptid
mimet
immun
similar
array
use
demonstr
potenti
crossreact
immun
respons
attenu
sar
vaccin
selfcarbohydr
move
toward
diagnost
glycoarray
globoh
hexsaccharid
cancer
marker
nine
analog
array
use
test
monoclon
antibodi
patient
sera
gobohspecif
bind
major
applic
array
dissect
chemic
biolog
pathogenhost
cell
attach
rare
potent
neutral
antibodi
protect
viral
challeng
vivo
anim
model
hiv
infect
bind
termin
man
residu
carbohydr
array
develop
character
affin
structur
specif
mannos
recognit
compar
mannosebind
protein
develop
carbohydr
templat
hiv
vaccin
design
influenza
virus
array
probe
basi
speci
specif
crucial
aspect
evalu
serotyp
pandem
potenti
viru
invad
cell
hemagglutinin
bind
cell
surfac
sialic
acid
residu
vari
structur
base
host
speci
anatom
locat
bind
hemagglutinin
variant
recov
pandem
circul
strain
glycan
array
demonstr
differ
recognit
carbohydr
linkag
characterist
avian
human
virus
respect
fucosyl
sulfat
interestingli
singl
amino
acid
chang
pandem
found
switch
specif
exclus
mix
specif
wherea
confer
complet
revers
differ
approach
use
array
detect
pathogen
directli
indirectli
bacteri
glycoconjug
array
interrog
sera
effort
determin
individu
prior
exposur
correspond
microb
similarli
host
carbohydr
glycoprotein
use
bacteri
receptor
array
follow
specif
captur
bacteria
bind
receptor
approach
even
allow
microorgan
recoveri
array
spot
subsequ
growth
antibiot
suscept
test
lectin
specif
determin
perhap
use
comprehens
glycan
array
protein
employ
gener
complementari
lectin
array
carbohydratebind
protein
immobil
incub
fluoresc
label
molecul
cell
assess
carbohydr
moieti
although
format
still
earli
stage
one
array
contain
commerci
avail
lectin
use
discrimin
strain
laboratori
pathogen
e
coli
bacteria
base
wholecel
bind
pattern
also
track
tempor
express
differ
glycan
growth
cycl
limit
number
wellcharacter
lectin
antibodi
avail
mechan
creat
lectin
divers
exist
natur
could
appli
engin
specif
lectin
properti
onethird
approv
biopharmaceut
glycoprotein
carbohydr
compon
long
known
affect
function
circul
half
life
solubl
antibodi
complement
activ
fcreceptor
bind
specif
effect
primari
forc
motiv
homogen
carbohydr
protein
therapeut
express
recombin
host
recent
discoveri
natur
occur
antibodi
glycoform
vari
abil
mediat
inflamm
cytotox
crucial
autoimmun
cancer
treatment
respect
provid
addit
impetu
control
posttransl
modif
lectin
array
could
aid
character
optim
monitor
qualiti
biolog
therapi
addit
concern
common
microarray
applic
advanc
sever
area
like
directli
applic
studi
infect
immun
one
approach
streamlin
clone
express
purif
entir
orfeom
antigen
array
method
includ
borrow
structur
genom
eg
tag
purif
immobil
gener
protein
directli
dna
eg
spot
viral
cell
particl
present
protein
interest
surfac
vitro
transcript
translat
spot
transcript
activ
dna
produc
directli
captur
express
protein
spot
lentivir
array
directli
transfect
overlaid
eukaryot
cell
second
import
area
develop
movement
array
format
technolog
expand
capabl
compar
current
array
measur
bind
nearequilibrium
condit
newer
format
extract
kinet
eg
biacor
flexchip
forc
eg
bioforc
nanosci
thermodynam
paramet
associ
interact
permit
rigor
quantit
comparison
provid
mechanist
insight
third
approach
involv
highthroughput
arraybas
analysi
addit
posttransl
modif
phosphoryl
lipid
mani
technic
hurdl
address
microarray
new
expand
capabl
figur
monitor
genom
pathogen
singl
nucleotid
precis
identifi
antigen
stimul
arm
immun
system
even
investig
role
posttransl
modif
new
array
use
probe
interact
immun
diseas
alreadi
result
signific
discoveri
regard
molecular
mechan
diseas
vaccin
develop
novel
therapeut
consist
histori
infecti
diseas
technolog
newer
technolog
lead
mani
excit
discoveri
complex
array
depend
eas
difficulti
produc
materi
use
array
element
differ
array
format
vari
greatli
number
uniqu
molecul
assess
rang
seven
newcom
pmhc
array
dna
oligonucleotid
array
